In animal studies, it was shown that in obese rats with diabetes by altering histone H3K9, dapagliflozin increases the synthesis of 3-hydroxybutyrate, which in turn upregulates adiponectin in adipocytes and increases insulin sensitivity in them. This evidence concerns the gene ADIPOQ and diabetes mellitus.